ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $41,000 | -32.8% | 870 | +2.1% | 0.00% | – |
Q1 2022 | $61,000 | +335.7% | 852 | +343.8% | 0.00% | – |
Q4 2021 | $14,000 | +40.0% | 192 | +5.5% | 0.00% | – |
Q3 2021 | $10,000 | +25.0% | 182 | -0.5% | 0.00% | – |
Q2 2021 | $8,000 | -27.3% | 183 | -20.8% | 0.00% | – |
Q1 2021 | $11,000 | +450.0% | 231 | +477.5% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 40 | +100.0% | 0.00% | – |
Q3 2020 | $1,000 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |